IDiyas

For the Inventor, By the Inventor

Gurnee, IL, United States of America

Mohamed-Eslam F Mohamed

USPTO Granted Patents = 36 

 

Average Co-Inventor Count = 6.4

ph-index = 18

Forward Citations = 593(Granted Patents)


Company Filing History:

goldMedal36 out of 822 
 
Abbvie Inc.
 patents

Years Active: 2018-2025

Loading Chart...
Loading Chart...
36 patents (USPTO):Explore Patents
1. 12365689 - Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof (2025-07-22),
2. 12134621 - Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof (2024-11-05),
3. 12116373 - Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof (2024-10-15),
4. 12110297 - Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof (2024-10-08),
5. 12103933 - Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof (2024-10-01),
6. 12091415 - Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof (2024-09-17),
7. 12077545 - Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof (2024-09-03),
8. 11993606 - Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof (2024-05-28),
9. 11993605 - Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof (2024-05-28),
10. 11976077 - Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms therof (2024-05-07),
11. 11795175 - Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof (2023-10-24),
12. 11787815 - Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof (2023-10-17),
13. 11780848 - Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1- carboxamide and solid state forms thereof (2023-10-10),
14. 11780847 - Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1- carboxamide and solid state forms thereof (2023-10-10),
15. 11773106 - Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof (2023-10-03),

Title: Innovations and Contributions of Mohamed-Eslam F Mohamed in Pharmaceutical Chemistry

Introduction

Mohamed-Eslam F Mohamed, based in Gurnee, IL, is an accomplished inventor in the field of pharmaceutical chemistry. With a remarkable portfolio of 35 patents, he has demonstrated significant contributions towards the development and synthesis of novel chemical compounds that play a crucial role in medical treatments.

Latest Patents

Among his most notable innovations are his latest patents related to the processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide. This disclosure specifically outlines procedures for preparing solid state forms of this compound, which is potentially impactful for pharmaceutical compositions and methods of treatment, including the management of rheumatoid arthritis. Furthermore, these patents detail kits, methods of synthesis, and products-by-process, making significant strides in the pharmaceutical industry.

Career Highlights

Currently, Mohamed-Eslam contributes his expertise at AbbVie Inc., a global biopharmaceutical company renowned for its innovations in various therapeutic areas. His role within the company emphasizes the application of his research and development skills to advance medical treatments and enhance patient care.

Collaborations

Throughout his career, Mohamed-Eslam has worked alongside notable colleagues such as Ahmed A Othman and Ben Klünder. These collaborations enhance the research environment and foster innovative solutions in the pharmaceutical sector, leveraging diverse expertise to tackle complex challenges.

Conclusion

In conclusion, Mohamed-Eslam F Mohamed's extensive work and patent portfolio place him among the leading inventors in pharmaceutical chemistry. His innovations not only contribute to scientific advancement but also hold the potential to transform treatment methodologies for various diseases. As he continues to work at AbbVie Inc., the future promises further developments that will undoubtedly impact the pharmaceutical landscape positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…